How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Dec 14
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Duke U, Mayo Clinic, et al collab for innovative AI

Oct 25
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharmacoprint: A Combination of a Pharmacophore Fingerprint and Artificial Intelligence as a Tool for Computer-Aided Drug Design

Nov 15
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial Intelligence In Drug Discovery

Oct 13
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

With the Metaverse on the way, an AI Bill of Rights is urgent

Jan 26
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Globalization and Democratization of Innovation

Dec 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Pharma giant collabs with CMU in AI academy launch

Sep 22
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Arabesque launches the world’s first AI-powered ESG portfolio manager

Aug 11
,
0221
AI
Cleantech
Healthcare
Investment
Life Science
Press

Major venture capital investment in European life sciences will fuel occupier market

Jan 10
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts discuss barriers to deep tech ventures

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Intelligence Artificielle : l'UM6P signe un partenariat avec la start-up ALPHA10X

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus